A spherical brain mapping of MR images for the detection of Alzheimer's disease
News May 20, 2016
Researchers propose a new framework for diagnosing Alzheimer's disease, namely spherical brain mapping (SBM) -
Diagnosis, treatment and care of dementia is one of the major concerns in neurology research and associated healthcare programs. Dementia affects older age groups with a greater frequency, and as our population ages, the burden of dementia on public health is rapidly increasing.
The most common cause of dementia is Alzheimer's disease (AD), which accounts for 60 to 80 per cent of total cases.
Much effort has been put into understanding its causes since, although still incurable, an early diagnosis can slow the progression of the disease, improving the quality of life of patients and their families.
Neuroimaging has proven as a very useful tool in the quest for detecting ad alleviating symptoms of dementia, allowing an in vivo assessment of the structural and functional properties of the brain, providing relevant data for the diagnostic task. Currently, the use of computational techniques to analyze neuroimaging data has provided us with unprecedented insight of the process of neurodegeneration in AD.
In new work published in Current Alzheimer's Research, researchers propose a new framework for dementia diagnosis, namely spherical brain mapping (SBM) that performs a projection of three-dimensional magnetic resonance (MR) brain images onto two-dimensional maps revealing statistical characteristics of the tissue.
Learn More: Epigenomics of Alzheimer’s disease progression
These maps can contain both meaningful features such as cortical thickness or surface and radial statistical features of the tissues, such as average, entropy, etc.
The resulting maps perform a significant feature reduction that will allow further supervised or unsupervised processing, reducing the computational load while maintaining a large amount of the original information.
This framework achieves a performance up to 91% accuracy in a differential diagnosis involving Alzheimer-affected subjects versus controls belonging to the Alzheimer's Disease Neuroimaging Initiative (ADNI). Additionally, these maps can be visually assessed and interpreted, which can be of great help in the diagnosis of AD and other types of dementia.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Martinez-Murcia FJ et al. A Spherical Brain Mapping of MR Images for the Detection of Alzheimer’s Disease. Current Alzheimer Research, Published 2016. doi: 10.2174/1567205013666160314145158
Researchers Find a Way to Separate Side Effects of Opioid Drugs Reducing RiskNews
Scientists have discovered a way to separate these two effects -- pain relief and breathing, opening a window of opportunity to make effective pain medications without the risk of respiratory failure.READ MORE
Biological Mechanism of a Leading Cause of Childhood Blindness RevealedNews
Scientists have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.READ MORE
Machine Learning: Helping Determine How a Drug Affects the BrainNews
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.READ MORE